Increased Circulating Levels of Tissue-Type Plasminogen Activator Are Associated with the Risk of Spontaneous Abortion During the First Trimester of Pregnancy.
early prediction
extracellular vesicles
prenatal care
spontaneous abortion
tissue plasminogen activator
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
01 Apr 2020
01 Apr 2020
Historique:
received:
05
02
2020
revised:
05
03
2020
accepted:
11
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
5
4
2020
Statut:
epublish
Résumé
Spontaneous abortion is a common complication in early pregnancy, with an incidence of around 20%. Ultrasound scan and measurement of human chorionic gonadotropin are used to identify patients at risk of spontaneous abortion; however, there is a clinical need to find new biomarkers to prospectively identify patients before the onset of clinical symptoms. Here, we aim to investigate potential biomarkers of spontaneous abortion taken in the first clinical appointment of pregnancy. A case-control study was conducted based on a prospectively collected cohort in which cases and controls were retrospectively stratified based on pregnancy outcome: normal healthy pregnancies (controls = 33) and pregnancies that ended in spontaneous abortion (cases = 10). We evaluated extracellular vesicles isolated by precipitation with ExoQuick™ and protein concentrations of tissue plasminogen activator, leptin, and adiponectin measured by ELISA. The extracellular vesicles showed the typical morphology and membrane proteins: CD63, Alix, and Flotilin-1. The size distributions of the isolated extracellular vesicles were 112 ± 27 and 118 ± 28 nm in diameter for controls and spontaneous abortion, respectively, and the total amount of extracellular vesicles did not show any difference between controls and the spontaneous abortion group. The tissue plasminogen activator showed a significant difference (
Identifiants
pubmed: 32244842
pii: diagnostics10040197
doi: 10.3390/diagnostics10040197
pmc: PMC7235768
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Diabetes. 2016 Mar;65(3):598-609
pubmed: 26718504
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3182-3194
pubmed: 28531338
Clin Exp Immunol. 2007 Jul;149(1):31-9
pubmed: 17425656
BMJ. 2012 Sep 27;345:e6077
pubmed: 23045257
Placenta. 2018 Apr;64:34-43
pubmed: 29626979
Clin Endocrinol (Oxf). 1999 Feb;50(2):211-6
pubmed: 10396364
J Clin Endocrinol Metab. 2014 Sep;99(9):3427-34
pubmed: 24796925
Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):169-78
pubmed: 24047642
Hum Reprod. 2001 Sep;16(9):2008-13
pubmed: 11527914
Clin Ther. 2014 Jun 1;36(6):830-46
pubmed: 24952934
Fertil Steril. 2012 Nov;98(5):1091-6
pubmed: 23084011
Hum Reprod. 1998 Nov;13(11):3220-7
pubmed: 9853884
Am J Obstet Gynecol. 1998 Aug;179(2):520-6
pubmed: 9731863
J Biol Regul Homeost Agents. 2013 Jan-Mar;27(1):225-31
pubmed: 23489701
Pathophysiol Haemost Thromb. 2003 May-Jun;33(3):134-7
pubmed: 15170393
J Perinatol. 2007 Feb;27(2):77-81
pubmed: 17262038
Fertil Steril. 2012 Nov;98(5):1074-7
pubmed: 23031160
Obesity (Silver Spring). 2013 Jan;21(1):210-6
pubmed: 23505188
Front Neurosci. 2017 May 22;11:278
pubmed: 28588440
Am J Obstet Gynecol. 2015 Oct;213(4 Suppl):S173-81
pubmed: 26428497
Fertil Steril. 2003 Mar;79(3):577-84
pubmed: 12620443
Thromb Haemost. 1984 Oct 31;52(2):176-82
pubmed: 6084322
BMJ. 1990 Jun 9;300(6738):1500
pubmed: 2115385
Proteomics. 2014 Mar;14(4-5):412-25
pubmed: 24339442
Pharmacol Rev. 2012 Jul;64(3):676-705
pubmed: 22722893
BJOG. 2002 Nov;109(11):1250-5
pubmed: 12452463
Hum Reprod Update. 2016 Jan-Feb;22(1):116-33
pubmed: 26386469
J Transl Med. 2014 Aug 08;12:204
pubmed: 25104112
Diabetes Care. 2013 Jun;36(6):1434-6
pubmed: 23704670
Rev Reprod. 2000 Jan;5(1):18-24
pubmed: 10711732
Int J Mol Sci. 2019 Jul 03;20(13):
pubmed: 31277271
Diabetes Care. 2004 Jan;27(1):274-5
pubmed: 14694004
J Appl Oral Sci. 2010 Sep-Oct;18(5):i
pubmed: 21085796
BJOG. 2000 Oct;107(10):1265-70
pubmed: 11028579